Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Edinburgh
About this trial
This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
A formal diagnosis of TAK
Disqualifiers
Age < 18 years
Lack of a formal diagnosis of TAK
Patients without mental capacity or willingness to provide informed consent
Not UK based
Trial population
Participants are UK-based
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Questionnaire
Other interventionAn online annoymous questionnaire consisting of short-answer and multiple-choice questions
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: Patients with Takayasu Arteritis1 intervention
Group B: Physicians Involved in the Management of Patients with Takayasu Arteritis1 intervention
Trial outcomes
Primary outcomes
1
Patient Perspective
To understand the lived experiences of individuals with TAK, including their symptoms, health status post-diagnosis, treatment priorities, and concerns. The questionnaire covers the following topics: * Basic background information * Living with Takayasu arteritis * Changes to health since diagnosis * Physical activity and exercise habits- measured by the International Physical Activity Questionnaire (IPAQ) * Smoking history * Mental well-being- measured by the EQ-5D instrument * Nutrition and diet * Personal views and priorities on management
Time frame
Day 12
Physician Perspective
To evaluate current clinical management strategies for TAK, identify treatment priorities, and highlight areas of unmet need in clinical practice. The physician questionnaire covers the following topics: * Clinical background and experience with TAK patients * Diagnostic and treatment strategies for TAK * Consideration of cardiovascular disease risk in TAK management * Physician priorities and unmet needs of management
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov